<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Cheminform</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Cheminform</journal-id>
    <journal-title-group>
      <journal-title>Journal of Cheminformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1758-2946</issn>
    <publisher>
      <publisher-name>Springer International Publishing</publisher-name>
      <publisher-loc>Cham</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8886843</article-id>
    <article-id pub-id-type="publisher-id">573</article-id>
    <article-id pub-id-type="doi">10.1186/s13321-021-00573-5</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>PSnpBind: a database of mutated binding site protein–ligand complexes constructed using a multithreaded virtual screening workflow</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8399-8990</contrib-id>
        <name>
          <surname>Ammar</surname>
          <given-names>Ammar</given-names>
        </name>
        <address>
          <email>a.ammar@maastrichtuniversity.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3796-1687</contrib-id>
        <name>
          <surname>Cavill</surname>
          <given-names>Rachel</given-names>
        </name>
        <address>
          <email>rachel.cavill@maastrichtuniversity.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5301-3142</contrib-id>
        <name>
          <surname>Evelo</surname>
          <given-names>Chris</given-names>
        </name>
        <address>
          <email>chris.evelo@maastrichtuniversity.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7542-0286</contrib-id>
        <name>
          <surname>Willighagen</surname>
          <given-names>Egon</given-names>
        </name>
        <address>
          <email>egon.willighagen@maastrichtuniversity.nl</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution>Department of Bioinformatics—BiGCaT, NUTRIM, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution>Department of Data Science and Knowledge Engineering, </institution><institution>Maastricht University, </institution></institution-wrap>Maastricht, The Netherlands </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>28</day>
      <month>2</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>28</day>
      <month>2</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>14</volume>
    <elocation-id>8</elocation-id>
    <history>
      <date date-type="received">
        <day>11</day>
        <month>8</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>18</day>
        <month>11</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">A key concept in drug design is how natural variants, especially the ones occurring in the binding site of drug targets, affect the inter-individual drug response and efficacy by altering binding affinity. These effects have been studied on very limited and small datasets while, ideally, a large dataset of binding affinity changes due to binding site single-nucleotide polymorphisms (SNPs) is needed for evaluation. However, to the best of our knowledge, such a dataset does not exist. Thus, a reference dataset of ligands binding affinities to proteins with all their reported binding sites’ variants was constructed using a molecular docking approach. Having a large database of protein–ligand complexes covering a wide range of binding pocket mutations and a large small molecules’ landscape is of great importance for several types of studies. For example, developing machine learning algorithms to predict protein–ligand affinity or a SNP effect on it requires an extensive amount of data. In this work, we present PSnpBind: A large database of 0.6 million mutated binding site protein–ligand complexes constructed using a multithreaded virtual screening workflow. It provides a web interface to explore and visualize the protein–ligand complexes and a REST API to programmatically access the different aspects of the database contents. PSnpBind is open source and freely available at <ext-link ext-link-type="uri" xlink:href="https://psnpbind.org">https://psnpbind.org</ext-link>.</p>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Binding affinity</kwd>
      <kwd>Mutation effect</kwd>
      <kwd>Binding pocket</kwd>
      <kwd>Virtual screening</kwd>
      <kwd>AutoDock Vina</kwd>
      <kwd>SNP</kwd>
      <kwd>Database</kwd>
      <kwd>REST API</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par13">Over the last 50 years, pharmacogenomics has studied the genetic basis for inter-individual drug response variability [<xref ref-type="bibr" rid="CR1">1</xref>]. Many factors are involved in patient-drug response, for instance, environmental and behavioral factors. At the same time, genetic factors also play an essential role [<xref ref-type="bibr" rid="CR2">2</xref>]. Genetic factors that can have functionally substantial consequences on drug response are numerous. For example, they include genetic variants’ effects on the protein structure and stability, DNA transcription, and mRNA regulation [<xref ref-type="bibr" rid="CR1">1</xref>]. Studies have shown that 80% of patients carry at least one functional variant in the drug targets of the top 100 most commonly prescribed drugs in the United States [<xref ref-type="bibr" rid="CR3">3</xref>]. The variation in drug-response at the protein level and its underlying mechanisms are of a significant interest in developing new drugs with an estimate of six single nucleotide polymorphisms (SNPs) affecting five different FDA-approved drugs carried by every individual [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
    <p id="Par14">Mutations that occur in the binding site of a target protein may change the protein–ligand binding affinity, which can lead to a substantially different phenotype resembling lower efficiency of the drug or higher off-target binding affinity that could lead to side effects [<xref ref-type="bibr" rid="CR5">5</xref>]. Nevertheless, large-scale studies of the effect of SNPs occurring at the binding site of proteins on a structural level do not exist to the best of our knowledge. Besides, studies often focus on one protein with a limited number of variants [<xref ref-type="bibr" rid="CR6">6</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. For example, Doss et al. studied the effects of SNPs in the anaplastic lymphoma kinase (ALK) protein on the patient’s drug response including 21 binding site related SNPs. Furthermore, these studies need substantial computational power because they mostly rely on demanding molecular dynamics simulations. As a result, performing such studies on a large-scale, including a wide range of proteins and ligands, is expensive and laborious.</p>
    <p id="Par15">Several studies [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR23">23</xref>] tackled the topic of creating a database or web server for mapping SNPs onto protein structures, as shown in Table <xref rid="Tab1" ref-type="table">1</xref>. However, we identified several issues after a thorough analysis of these resources. For example, none of these projects provide data about the binding site residues’ mutations or their effect on ligand binding. Besides, most of them [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>] are either no longer available or outdated. Others [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] are not downloadable and do not provide application programming interfaces (APIs) for programmatic access. Having a large database of protein-ligand complexes covering a wide range of binding pocket mutations and a large small molecules’ landscape is of great importance for several types of studies. For example, developing machine learning algorithms to predict protein–ligand affinity or a SNP effect on it requires an extensive amount of data with a wide coverage of mutation types and small molecules. Also, studies of protein–ligand interactions and conformer orientation changes across different mutated versions of a protein require such a database.</p>
    <p id="Par16">For those reasons, we decided to develop the PSnpBind database (<ext-link ext-link-type="uri" xlink:href="https://psnpbind.org">https://psnpbind.org</ext-link>) to address the lack of large datasets about the binding affinity of binding site mutated protein-ligand complexes and to provide a base for new studies in related fields like drug discovery, pharmacogenomics, and structural bioinformatics.<table-wrap id="Tab1"><label>Table 1</label><caption><p>List of databases related to SNPs effect analysis and visualization</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><bold>Database</bold></th><th align="left"><bold>Last update</bold></th><th align="left"><bold>Comment</bold></th></tr></thead><tbody><tr><td align="left">MSV3d [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">2016, Not downloadable, (web only)</td><td align="left">Mutated structures built using MODELLER. The website also contains conservation and physio-chemical changes. SwissVar and dbSNP are the main sources of SNPs</td></tr><tr><td align="left">PinSnps [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left">2013</td><td align="left">Exploring the impact of SNPs on Protein Domains and Complexes</td></tr><tr><td align="left">LS-SNP/PDB [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td align="left">2009, Not available anymore</td><td align="left"/></tr><tr><td align="left">G23D [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td align="left">2016, Not downloadable, (web only)</td><td align="left">Used software: SCCCOMP and SCWRL for Side chain modeling, JSmol for molecular graphics, I-mutant and FoldX for thermostability prediction</td></tr><tr><td align="left">SNPs3D [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td align="left">2008, Not downloadable</td><td align="left">SNP impact on protein structure and function. A Support Vector Machine (SVM) model was used to find the separation pattern between a set of diseases and non-deleterious SNPs. The resulting pattern was then validated using a different set of diseases and non-deleterious SNPs.</td></tr><tr><td align="left">SAAPdb [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td align="left">No longer maintained</td><td align="left">A newer project SAAPdap/SAAPpred is available - analysis pipeline for examining the structural effects of mutations/prediction of pathogenicity.</td></tr><tr><td align="left">SNP2Structure [<xref ref-type="bibr" rid="CR20">20</xref>]</td><td align="left">Not available anymore</td><td align="left"/></tr><tr><td align="left">PhyreRisk [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">2019, Not downloadable (web only)</td><td align="left">A dynamic web application to bridge genomics, proteomics and 3D structural data to guide interpretation of human genetic variants.</td></tr><tr><td align="left">toposnp [<xref ref-type="bibr" rid="CR21">21</xref>]</td><td align="left">2019, Databases are up to date, Not downloadable, (web only)</td><td align="left">Topographic mapping of Single Nucleotide Polymorphism</td></tr><tr><td align="left">coliSNP [<xref ref-type="bibr" rid="CR22">22</xref>]</td><td align="left">Not available anymore</td><td align="left"/></tr><tr><td align="left">StructMAn [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td align="left">2016, Not downloadable (web only)</td><td align="left">Annotation of non-synonymous single-nucleotide polymorphisms (nsSNPs) in the context of the structural neighbourhood of the resulting amino acid variations in the protein.</td></tr></tbody></table></table-wrap></p>
  </sec>
  <sec id="Sec2">
    <title>Construction and content</title>
    <p id="Par17">Figure <xref rid="Fig1" ref-type="fig">1</xref> shows the methodology of PSnpBind database construction. The methodology is composed of 7 steps targeting three main processes: protein structures preparation, ligand structures preparation and protein–ligand docking. The following subsections explains in detail each step of the methodology.</p>
    <sec id="Sec3">
      <title>Data sources</title>
      <p id="Par18">Several data sources were used to integrate the information about proteins (structures, sequences, and variants), ligands structures and protein-ligand complexes structures and relevant information. Figure <xref rid="Fig1" ref-type="fig">1</xref> shows the main data sources used and the filtering criteria applied on each one.</p>
      <sec id="Sec4">
        <title>PDBbind</title>
        <p id="Par19">PDBbind [<xref ref-type="bibr" rid="CR25">25</xref>] provides a comprehensive collection of the experimentally measured binding affinity data for all types of biomolecular complexes deposited in the Protein Data Bank [<xref ref-type="bibr" rid="CR26">26</xref>]. The entire PDB was screened to identify complexes and build the PDBbind database. This data source provides the biomolecular complexes grouped into four groups (protein–ligand, protein-nucleic acid, nucleic acid-ligand, and protein-protein complexes). For our project, we were only interested in protein-ligand complexes which are also distributed over three datasets:<list list-type="bullet"><list-item><p id="Par20">General set: all protein–ligand complexes from PDB.</p></list-item><list-item><p id="Par21">Refined set: a standard data set for docking and scoring studies.</p></list-item><list-item><p id="Par22">Core set: includes high-resolution crystal structures and reliable binding constants.</p></list-item></list>Building the PDBbind database included collecting all the complexes from PDB without performing structural optimization or any type of transformation on the coordinates. Binding affinity data (dissociation constant (K<sub>d</sub>), inhibition constant (K<sub>i</sub>), and concentration at 50% inhibition (IC<sub>50</sub>)) were collected from the primary references of the deposited entries. The authors applied a priority order of K<sub>d</sub> &gt; K<sub>i</sub> &gt; IC<sub>50</sub> when more than one value appeared in the references, and they only recorded the data with the highest priority. Also, in case of binding affinities measured under different conditions (temperature and pH) for any complex, only the results measured at neutral pH and room temperature or in assay conditions close to that were recorded.</p>
        <p id="Par23">PDBbind also provides a residue-level annotation for the amino acids involved in the binding pockets of the protein-ligand complexes. It is a crucial piece of information for our project to map the missense SNPs onto the binding pocket residues.</p>
        <p id="Par24">We chose to use the PDBbind core set version 2016 (also called Comparative Assessment of Scoring Functions “CASF” dataset) in this work mainly because it is a concise version of the refined set where all redundancy is eliminated. Besides, the size of the dataset is smaller and more practical to work with. CASF 2016 was downloaded on October 6th, 2019, from the PDBbind website, and contained 285 high-quality protein–ligand complexes, out of which 123 complexes are for human proteins.</p>
      </sec>
      <sec id="Sec5">
        <title>UniProt</title>
        <p id="Par25">UniProt [<xref ref-type="bibr" rid="CR27">27</xref>] was used as a source for protein sequences and human protein variants. The human variants dataset from UniProt contained the amino acid substitutions resulting from missense SNPs in the protein-coding regions in the human genome. UniProt provides manually reviewed protein-altering natural variants imported from the publicly accessible variant resources such as Ensembl Variation [<xref ref-type="bibr" rid="CR28">28</xref>] and ClinVar [<xref ref-type="bibr" rid="CR29">29</xref>] databases. Four types of variants are included in this dataset annotated with Sequence Ontology (SO) identifiers: missense variants (SO:0001582), stop lost (SO:0001578), stop gained (SO:0001587), and initiator codon variants (SO:0001582). The version released on October 16th, 2019 was used and only the missense variants were considered. The used version contains about 29 million variants occurring in about 19000 human genes.</p>
      </sec>
      <sec id="Sec6">
        <title>SIFTS</title>
        <p id="Par26">SIFTS (Structure Integration with Function, Taxonomy, and Sequence) is a project in the PDBe-KB resource for residue-level mapping between UniProt and PDB entries [<xref ref-type="bibr" rid="CR30">30</xref>]. It is a close collaboration between the Protein Data Bank in Europe (PDBe) and UniProt. It uses NCBI taxonomic identifiers as a standard way of representing taxonomic information for all PDB entries within the PDBe database. For all the protein sequences in the PDB that are present in the UniProt database, cross-references to UniProtKB are added in SIFTS. SIFTS provides an accurate mapping of the sequences from PDB entries on to corresponding UniProt entries. It also contains a mapping to both:<list list-type="bullet"><list-item><p id="Par27">SEQRES record in the PDB entry: the complete sequence of the protein used in the experiment.</p></list-item><list-item><p id="Par28">ATOM record in the PDB entry: the observed residues in the crystal structure.</p></list-item></list>This dataset is a vital resource in this project in order to be able to map the protein-altering variants in the protein sequence to the binding pocket residues in the crystal structure.</p>
      </sec>
      <sec id="Sec7">
        <title>ChEMBL</title>
        <p id="Par29">ChEMBL is an open database that contains functional, binding, and ADMET information for many drug-like bio-active compounds (about two million compounds) [<xref ref-type="bibr" rid="CR31">31</xref>]. It is maintained by the European Bioinformatics Institute (EBI), of the European Molecular Biology Laboratory (EMBL), based at the Wellcome Trust Genome Campus, Hinxton, UK. The data in ChEMBL is manually curated from thousands of publications and dozens of deposited datasets. The need for a chemical compounds dataset is to create a chemical library from similar compounds to the ones selected from PDBbind.</p>
        <p id="Par30">The created library was used to perform molecular docking against the proteins selected from PDBbind with their mutated version to obtain a reference dataset large enough to train a machine learning model on it. ChEMBL version 25, released on February 1st, 2019, was used in this work.<fig id="Fig1"><label>Fig. 1</label><caption><p>Methodology workflow. Steps 1, 2 and 3 filter the data from the main sources and map them together. Step 4 and 5 prepare the selected protein PDBs and their mutated versions for docking. Step 6 prepares the ligands. Step 7 performs the docking</p></caption><graphic xlink:href="13321_2021_573_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Dataset construction</title>
      <p id="Par31">To build the dataset of mutated protein-ligand complexes, we needed to identify the natural mutations occurring in binding pockets of human proteins selected from CASF. The next sections describe the process in detail.</p>
      <sec id="Sec9">
        <title>Steps 1, 2, and 3: obtaining the list of CASF human proteins binding pockets missense variants</title>
        <p id="Par32">First, the PDBbind dataset was downloaded and filtered to include only high-resolution structures obtained with X-ray crystallography (resolution <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\le$$\end{document}</tex-math><mml:math id="M2"><mml:mo>≤</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq1.gif"/></alternatives></inline-formula> 2.5 Å). Even though PDBbind contains structures obtained by both X-ray and NMR, we only selected the X-ray based structures as the number of NMR structures is tiny compared to X-ray. There are differences between the two approaches with effects on the obtained structures like the number of inter-residue contacts and the main-chain hydrogen bonds [<xref ref-type="bibr" rid="CR32">32</xref>]. These differences will, therefore, require performing different kinds of preprocessing and analysis, and since the number of NMR structures is low, we decided to ignore them.</p>
        <p id="Par33">In X-ray crystallography, heavy atoms scatter the X-rays resulting in a diffraction pattern. This pattern can be computationally converted back to a detailed protein structure. Resolution is a measure of the level of detail present in the diffraction pattern. A threshold of 2.5 Å for structure resolution was used [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] to ensure that atomic details can be seen, while in structures with low resolution, only the basic contours of the protein chain can be seen.</p>
        <p id="Par34">The entries of PDBbind were also filtered to include only the ones with a UniProt ID. The dataset included multiple complex structures for the same UniProt proteins (i.e., proteins complexed with more than one ligand). Therefore, entries were aggregated by UniProt ID, and the proteins with the highest resolution were selected from each group. Each ligand that shares a complex with those proteins was also stored.</p>
        <p id="Par35">Next, the variant data from UniProt was downloaded and filtered to only include missense variants. Then, by doing an “inner join” over the UniProt ID column between the UniProt variants and the PDBbind entries selected from the previous step, only those missense variants occurring in the proteins of the PDBbind entries list were selected. All the duplicates were removed, and the joining resulted in 11749 missense variants belonging to 26 proteins (26 unique UniProt IDs). Since the variants dataset only contains human variants, the resulting dataset only contained human proteins with their variants. Table <xref rid="Tab2" ref-type="table">2</xref> shows an example list of filtered variants from the UniProt variant dataset.</p>
        <graphic position="anchor" xlink:href="13321_2021_573_Figa_HTML" id="MO2"/>
        <p id="Par36">After that, the SIFTS mappings for the 26 human proteins were downloaded from the PDB website. Next, the BioJava [<xref ref-type="bibr" rid="CR35">35</xref>] library was used to parse the SIFTS mappings. In conjunction with the binding pocket annotations (binding pockets residue numbers) of the PDBbind entries, only those variants occurring in the binding pocket were retained. All the duplicates were removed, and the joining resulted in 705 missense variants belonging to 26 protein binding pockets (26 unique UniProt IDs). Algorithm 1 shows pseudocode for the matching between variants sequence location and pocket residues in the PDB structure.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Example list of CASF human proteins variants selected from the UniProt variants dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><bold>Uniprot ID</bold></th><th align="left"><bold>Missense SNP</bold></th><th align="left"><bold>PDB ID</bold></th><th align="left"><bold>Source AA</bold></th><th align="left"><bold>Target AA</bold></th><th align="left"><bold>Residue Num.</bold></th><th align="left"><bold>Chain</bold></th></tr></thead><tbody><tr><td align="left">O14757</td><td align="left">p.Leu92Phe</td><td align="left">3jvr</td><td align="left">L</td><td align="left">F</td><td char="." align="char">92</td><td align="left">A</td></tr><tr><td align="left">O14757</td><td align="left">p.Phe93Val</td><td align="left">3jvr</td><td align="left">F</td><td align="left">V</td><td char="." align="char">93</td><td align="left">A</td></tr><tr><td align="left">O14757</td><td align="left">p.Ile96Val</td><td align="left">3jvr</td><td align="left">I</td><td align="left">V</td><td char="." align="char">96</td><td align="left">A</td></tr><tr><td align="left">O14757</td><td align="left">p.Gly101Cys</td><td align="left">3jvr</td><td align="left">G</td><td align="left">C</td><td char="." align="char">101</td><td align="left">A</td></tr><tr><td align="left">O14965</td><td align="left">p.Gly140Ala</td><td align="left">3up2</td><td align="left">G</td><td align="left">A</td><td char="." align="char">140</td><td align="left">A</td></tr></tbody></table></table-wrap></p>
        <p id="Par37">The residues where the mutations occurred were further analyzed to understand their nature by assigning the wildtype and the mutation amino acids in each residue location to one of the seven functional categories (polar, non-polar, neutral polar, charged polar, negatively charged, positively charged). Next, an UpSet plot was generated to quantify the frequency of the mutation types (transition from one group to another) across the 26 proteins in the dataset. The UpSet plot was generated using the ComplexHeatmap R package [<xref ref-type="bibr" rid="CR36">36</xref>] as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>.</p>
        <p id="Par38">Figure <xref rid="Fig2" ref-type="fig">2</xref> shows, on the X-axis, the mutation types intersections reported in the obtained dataset (steps 1,2 and 3). For example, on the far left, there is one protein having binding pocket mutations from all the seven mutation types. Similarly, on the far right, there is one protein with only one type of mutation (same functional group, in this case). Also, a third example from the middle, there are 6 proteins having mutations belonging to four types (same functional group, polar to non-polar, non-polar to polar and charged to neutral). On the other hand, on the Y-axis, it shows the number of proteins having a certain type of mutation. For example, on top, there are 24 proteins having mutations from the “Same functional group” type. Another example, the last row, there are five proteins having mutations of the type “positive to negative”.<fig id="Fig2"><label>Fig. 2</label><caption><p>UpSet plot showing the availability of mutation types across the selected PSnpBind proteins. X-axis shows the number of proteins having the corresponding intersection between the mutation types. Y-axis shows the number of proteins having each mutation type</p></caption><graphic xlink:href="13321_2021_573_Fig2_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec10">
        <title>Step 4: Introducing the missense variants to the protein structures</title>
        <p id="Par39">After finding the missense variants in the binding pockets of the selected proteins, mutations were introduced to the protein structures using FoldX version 5.0 [<xref ref-type="bibr" rid="CR37">37</xref>], one of the best stability predictors upon mutation [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. In this process, the targeted amino acid needs to be replaced with the mutated amino acid, and a proper side chain must be determined. Also, the structure needs to be optimized to incorporate the physio-chemical changes resulting from substituting the amino acid, and FoldX takes care of modeling these changes. FoldX is an empirical force field developed to evaluate the effect of mutations on the folding, stability, and dynamics of proteins and nucleic acids in a fast manner. FoldX identifies the most likely mutant residue side-chain rotamers taking into consideration the laws governing preserved angle conservation. FoldX utilizes a linear combination of empirical terms to calculate the energy fold change upon inducing the mutation, representing the effect of mutations on the protein structure in kcal/mol as described in its main work [<xref ref-type="bibr" rid="CR37">37</xref>].</p>
        <p id="Par40">The FoldX “BuildModel” command takes the PDB structure file as input besides a text file named “individual_list.txt” containing the mutations wanted to be introduced to the structure separated by a comma. The syntax of representing the mutation in FoldX is (WT residue, chain, residue number, mutant residue). In our case, we only need to introduce a single mutation at a time, so we do not have comma-separated values. For example, using the variant information from Table <xref rid="Tab2" ref-type="table">2</xref>, the mutations list would be as follows:<list list-type="bullet"><list-item><p id="Par41">LA92F;</p></list-item><list-item><p id="Par42">FA93V;</p></list-item><list-item><p id="Par43">IA96V;</p></list-item><list-item><p id="Par44">GA101C;</p></list-item><list-item><p id="Par45">GA101S;</p></list-item><list-item><p id="Par46">RA137C;</p></list-item><list-item><p id="Par47">RA137G;</p></list-item><list-item><p id="Par48">RA137H;</p></list-item><list-item><p id="Par49">GA140A;</p></list-item></list></p>
      </sec>
      <sec id="Sec11">
        <title>Step 5: Energy minimization for the protein structures</title>
        <p id="Par50">The next step is energy minimization (EM) on the mutated protein structures. Gromacs version 2019.3 [<xref ref-type="bibr" rid="CR40">40</xref>] with CHARMM27 force field (which is CHARMM22 that is revised to include CMAP corrections and bundled with the CHARMM program version 27) [<xref ref-type="bibr" rid="CR41">41</xref>] and the TIP3P water model [<xref ref-type="bibr" rid="CR42">42</xref>] were used to remove bad contacts, hindrance-causing torsion angles, etc.</p>
        <p id="Par51">The protein structures were solvated in a cubic box of TIP3P water molecules at a distance of 1.2 nm (12 Å) from the solvent. The system’s net charge was neutralized by adding enough ions in correspondence to the type and amount of the protein charge. A cutoff of 1.2 nm for both short-range van der Waals and electrostatic interactions was used, and PME (Particle Mesh Ewald) was used for long-range interactions in all minimizations.</p>
        <p id="Par52">For structures that contained ions in the binding site, those ions were added and position restraints were applied to the protein structure. Metal ions play important roles in biological processes like respiration and the structural stability of protein folds [<xref ref-type="bibr" rid="CR43">43</xref>]. For example, one or two zinc ions (Zn<sup>2+</sup>) can be coordinated in a small protein structural motif, called “zinc finger,” which can be found in protein binding pockets in order to stabilize the fold.</p>
        <p id="Par53">Energy minimization was performed using the steepest descent algorithm. A maximum force of 100 kJ/mol/nm on any atom of the system was set as the end goal for convergence. A maximum number of 50000 steps of minimization was used. After EM, a potential energy plot was generated for each simulation to examine how the minimization went.</p>
        <p id="Par54">Lastly, simulation trajectories were exported to the final PDB files using the “trjconv” program in Gromacs. Figure <xref rid="Fig3" ref-type="fig">3</xref> shows a flowchart of Gromacs EM and MD simulations redrawn from [<xref ref-type="bibr" rid="CR44">44</xref>]. Gromacs energy minimization protocol was followed from [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], and the Gromacs manual (<ext-link ext-link-type="uri" xlink:href="http://manual.gromacs.org/documentation/2019/manual-2019.pdf">http://manual.gromacs.org/documentation/2019/manual-2019.pdf</ext-link>), and several settings and configurations were examined from the literature [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>Gromacs energy minimization flowchart</p></caption><graphic xlink:href="13321_2021_573_Fig3_HTML" id="MO4"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Step 6: Obtaining similar ligands for docking</title>
        <p id="Par55">A library of chemical compounds needs to be created to carry out a docking experiment against the mutated proteins. This library needs to be large enough to build a reference dataset of mutated protein–ligand binding affinities. Since the set of ligands binding to the selected proteins from PDBbind is too small to train a robust machine learning model that covers a wide range of ligands, such a library is needed.</p>
        <p id="Par56">ChEMBL [<xref ref-type="bibr" rid="CR31">31</xref>] was chosen as a source for chemical compounds because it only contains bio-active compounds, and that aligns with the protein-ligand docking use case, the aim of the work. OpenBabel toolbox version 2.3.2 was used to prepare the chemical compounds sets [<xref ref-type="bibr" rid="CR49">49</xref>] as in the following paragraphs. The ChEMBL dataset was downloaded in structure-data file format (SDF), and OpenBabel was used to create a fast search index. The index is a new file that stores a database of fingerprints for the molecules indexed. However, the index will allow significantly faster searching and similarity comparisons. The default fingerprint in OpenBabel was used to perform similarity search which is FP2, a path-based fingerprint which indexes small molecule fragments based on linear segments of up to 7 atoms.</p>
        <p id="Par57">Next, for each group of ligands belonging to a selected PDBbind entry, a similarity search was performed against ChEMBL to select similar compounds to each one of them. A similarity threshold (Tanimoto index) of 0.6 was chosen. The rationale behind choosing a low threshold is the need for compounds with a low similarity that will probably result in a low binding affinity. Including low binding affinities helps to cover a wider distribution of binding affinities which can be used to train machine learning models for binding affinity prediction applications. The Tanimoto index is a popular similarity coefficient used to measure the similarity between pairs of molecules [<xref ref-type="bibr" rid="CR50">50</xref>]. The Tanimoto Similarity Coefficient is a generalization of Jaccard similarity, which is applicable only for binary data. In the case of OpenBabel, Tanimoto similarity is applied to fingerprints generated for molecules as vectors of binary values. The Tanimoto coefficient takes values between 0 and 1 (where 1 is the highest similarity).</p>
        <p id="Par58">Next, the similar molecules collected as a single file were split into one file per molecule, and converted to mol2 format needed for molecular docking. After that, the resulting molecules were energy minimized with OpenBabel using the MMFF94 force field [<xref ref-type="bibr" rid="CR51">51</xref>]. The energy minimization of the ligands was performed using the steepest descent algorithm with a maximum step count of 2500. The molecules that failed the minimization were excluded from docking experiments.</p>
      </sec>
      <sec id="Sec13">
        <title>Step 7: protein–ligand docking using AutoDock Vina</title>
        <p id="Par59">Modulating the function of proteins by small molecules has been an active research area with applications in drug design and development. To quantify the binding of a ligand to its target protein, a commonly used measure is their binding affinity, which describes how strongly the ligand binds to its biological counterpart. Binding strength can be measured experimentally by Microscale thermophoresis (MST, labelled and unlabeled proteins) [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>], Nuclear Magnetic Resonance techniques (NMR) [<xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR56">56</xref>], Isothermal Titration Calorimetry (ITC), Surface Plasmon Resonance (SPR), and Fluorescence Polarization (FP) methods [<xref ref-type="bibr" rid="CR57">57</xref>]. Computational methods for the calculation of binding affinity range from rough estimates as in molecular docking, to more rigorous force fields in molecular dynamics (MD) simulations and Quantum Mechanical (QM) calculation [<xref ref-type="bibr" rid="CR57">57</xref>].</p>
        <p id="Par60">Predicting interactions between ligands and proteins is a crucial element in the drug discovery process [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. In order to perform a quick search for molecules that may bind to targets of biological interest, computational techniques such as structure-based drug designing (SBDD) are carried out. SBDD includes structure-based virtual screening (SBVS) or molecular docking, followed by Molecular Dynamics [<xref ref-type="bibr" rid="CR58">58</xref>]. Due to its ability to predict the ligand-binding affinity and conformation inside the receptor binding site with high accuracy, molecular docking is one of the most frequently used methods in SBDD [<xref ref-type="bibr" rid="CR58">58</xref>]. A thorough search in three-dimensional spaces is performed by docking methods to find probable interactions, and a scoring function is used to rank the candidates correctly.</p>
        <p id="Par61">The molecular docking was performed using AutoDock Vina software [<xref ref-type="bibr" rid="CR59">59</xref>]. AutoDock Vina was developed with ease of use in mind. It fulfills the need of a full-stack docking method that requires no expert knowledge to perform. It is freely available and uses well-tested default methods to perform highly optimized docking experiments. AutoDock Vina provides the binding affintiy as an approximation of the change in Gibbs free energy (<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta G$$\end{document}</tex-math><mml:math id="M4"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq2.gif"/></alternatives></inline-formula> or delta G), which is a negative number when the protein-ligand system reaches an equilibrium state.The magnitude of the negative <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta G$$\end{document}</tex-math><mml:math id="M6"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq3.gif"/></alternatives></inline-formula> determines the protein–ligand stability, or alternatively, the binding affinity. AutoDock Vina computationally calculate the <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta G$$\end{document}</tex-math><mml:math id="M8"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mi>G</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq4.gif"/></alternatives></inline-formula> using a scoring function to obtain the lowest-scoring conformation and reports the binding affinity using kcal/mol as the unit of binding affinity. The docking requires two main inputs, coordinates for receptor and ligand, to find the ideal docking poses. Receptor coordinates can be obtained from crystallography or NMR spectroscopy, while ligand coordinates are usually generated from SMILES [<xref ref-type="bibr" rid="CR60">60</xref>] (Simplified Molecular-Input Line-Entry System) strings.</p>
        <p id="Par62">The docking protocol was followed from [<xref ref-type="bibr" rid="CR61">61</xref>]. First, the protein structures as PDB files were prepared using AutoDockTools 1.5.6 (ADT). In this step, atom coordinates were parsed, and “autodock type” was assigned to each atom by ADT. Next, all hydrogens were added, non-polar hydrogens were merged, and the formatted receptor was written to a ’pdbqt’ file. A similar process was performed for the ligands, which were provided as mol2 files. Ligands files were parsed, and atom types were assigned to each atom. Next, all hydrogens were added, non-polar hydrogens were merged, rotatable bonds were defined, and the formatted ligands were written to a ’pdbqt’ file. Autodock Vina still needs a configuration file besides the receptor and ligand files.</p>
        <p id="Par63">The configuration file contains coordinates and dimensions of the grid box where the docking will take place. The grid box, when the binding pocket is known, should encapsulate the binding pocket and cover the entire cavity to where the ligand may bind. Defining the grid box was implemented programmatically by reading the coordinates of the binding pocket residues (since the pocket is annotated in PDBbind). Next, the coordinates of the grid box corners were defined to include all the atoms of all pocket residues. The center of the search space was set to be the center of the grid box. None of the grid boxes exceeded 27000 Å<sup>3</sup> of volume, which is the recommended threshold by Autodock Vina, where large search spaces increase the docking time and require a more exhaustive search. The number of poses to be returned was set to 3, and the search exhaustiveness was set to 12 (default 8) to ensure better coverage of the search space and the binding poses. The docking experiment’s implementation used both internal and external parallelization by utilizing multiple cores (12 cores) for the single docking experiment provided by the “cpu” configuration parameter, and running multiple dockings in parallel at the time as recommended by an extensive study on AutoDock Vina in [<xref ref-type="bibr" rid="CR62">62</xref>].</p>
        <p id="Par64">Since Vina uses a stochastic search method, random numbers are used in the process. Therefore, a seed was used to allow reproducibility. Also, the same seed was used for all performed docking experiments. The same parameters were also unified to ensure maximum reproducibility on the computing platform used for conducting the experiment. To test if the seed has an effect on the docking results, 10 random seeds were tested by performing the docking on the 26 selected protein–ligand CASF entries and calculating the correlation with the experimental values for each docking set. The evaluation didn’t result a considerable change in the docking behaviour. The dockings were performed using ten nodes in the data science research infrastructure provided by our institution (DSRI, <ext-link ext-link-type="uri" xlink:href="https://maastrichtu-ids.github.io/dsri-documentation/">https://maastrichtu-ids.github.io/dsri-documentation/</ext-link>) (128 CPUs each). The time required for each docking was recorded along with CPU usage. Table <xref rid="Tab3" ref-type="table">3</xref> shows a summary of the proteins, mutations, ligand, and dockings performed to obtain a reference data set for binding affinities. The docking experiments result logs were parsed and aggregated for further analysis of the docking performance.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Summary of selected protein structures, mutations, ChEMBL selected ligands, and the number of dockings ordered by the PDB ID</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><bold>UniProt ID</bold></th><th align="left"><bold>PDB ID</bold></th><th align="left"># <bold> of protein structures</bold></th><th align="left"># <bold>of ligands</bold></th><th align="left"># <bold> of dockings</bold></th></tr></thead><tbody><tr><td align="left">P00749</td><td align="left">1owh</td><td char="." align="char">38</td><td char="." align="char">1901</td><td char="." align="char">72225</td></tr><tr><td align="left">P11309</td><td align="left">2c3i</td><td char="." align="char">18</td><td char="." align="char">1240</td><td char="." align="char">22316</td></tr><tr><td align="left">P18031</td><td align="left">2hb1</td><td char="." align="char">18</td><td char="." align="char">419</td><td char="." align="char">7531</td></tr><tr><td align="left">P03372</td><td align="left">2pog</td><td char="." align="char">13</td><td char="." align="char">7017</td><td char="." align="char">91214</td></tr><tr><td align="left">P00918</td><td align="left">2weg</td><td char="." align="char">22</td><td char="." align="char">1013</td><td char="." align="char">22281</td></tr><tr><td align="left">P00742</td><td align="left">2y5h</td><td char="." align="char">33</td><td char="." align="char">667</td><td char="." align="char">22010</td></tr><tr><td align="left">P07900</td><td align="left">3b27</td><td char="." align="char">21</td><td char="." align="char">1954</td><td char="." align="char">41023</td></tr><tr><td align="left">P10275</td><td align="left">3b5r</td><td char="." align="char">83</td><td char="." align="char">466</td><td char="." align="char">38671</td></tr><tr><td align="left">P39086</td><td align="left">3fv1</td><td char="." align="char">43</td><td char="." align="char">345</td><td char="." align="char">14782</td></tr><tr><td align="left">O14757</td><td align="left">3jvr</td><td char="." align="char">11</td><td char="." align="char">631</td><td char="." align="char">6933</td></tr><tr><td align="left">P24941</td><td align="left">3pxf</td><td char="." align="char">10</td><td char="." align="char">505</td><td char="." align="char">5044</td></tr><tr><td align="left">P37231</td><td align="left">3u9q</td><td char="." align="char">20</td><td char="." align="char">606</td><td char="." align="char">12114</td></tr><tr><td align="left">P56817</td><td align="left">3udh</td><td char="." align="char">5</td><td char="." align="char">2127</td><td char="." align="char">10635</td></tr><tr><td align="left">O14965</td><td align="left">3up2</td><td char="." align="char">18</td><td char="." align="char">895</td><td char="." align="char">16109</td></tr><tr><td align="left">P00734</td><td align="left">3utu</td><td char="." align="char">27</td><td char="." align="char">1796</td><td char="." align="char">48492</td></tr><tr><td align="left">P03951</td><td align="left">4crc</td><td char="." align="char">50</td><td char="." align="char">690</td><td char="." align="char">34496</td></tr><tr><td align="left">Q16539</td><td align="left">4dli</td><td char="." align="char">9</td><td char="." align="char">1320</td><td char="." align="char">11878</td></tr><tr><td align="left">P23458</td><td align="left">4e5w</td><td char="." align="char">9</td><td char="." align="char">1090</td><td char="." align="char">9801</td></tr><tr><td align="left">P39900</td><td align="left">4gr0</td><td char="." align="char">38</td><td char="." align="char">1090</td><td char="." align="char">41419</td></tr><tr><td align="left">Q9H2K2</td><td align="left">4j21</td><td char="." align="char">17</td><td char="." align="char">3295</td><td char="." align="char">56001</td></tr><tr><td align="left">O60674</td><td align="left">4jia</td><td char="." align="char">7</td><td char="." align="char">848</td><td char="." align="char">5930</td></tr><tr><td align="left">Q08881</td><td align="left">4m0y</td><td char="." align="char">19</td><td char="." align="char">169</td><td char="." align="char">3197</td></tr><tr><td align="left">P00519</td><td align="left">4twp</td><td char="." align="char">26</td><td char="." align="char">795</td><td char="." align="char">20662</td></tr><tr><td align="left">O60885</td><td align="left">4wiv</td><td char="." align="char">3</td><td char="." align="char">917</td><td char="." align="char">2747</td></tr><tr><td align="left">P04637</td><td align="left">5a7b</td><td char="." align="char">160</td><td char="." align="char">113</td><td char="." align="char">17996</td></tr><tr><td align="left">Q9Y233</td><td align="left">5c28</td><td char="." align="char">13</td><td char="." align="char">352</td><td char="." align="char">4567</td></tr><tr><td align="left"/><td align="left">Total</td><td char="." align="char">731</td><td char="." align="char">32261</td><td char="." align="char">640074</td></tr></tbody></table></table-wrap></p>
        <p id="Par65">The duration of each docking experiment and the CPU usage was recorded. Twelve cores were allocated for each docking, so the CPU usage value is a percentage of 1200%. The CPU usage and docking durations were grouped by the number of torsion angles of the ligands, respectively, and the median was calculated for each group. Figure <xref rid="Fig4" ref-type="fig">4</xref> shows the relation between the number of torsion angles and the docking duration. Similarly, Fig. <xref rid="Fig5" ref-type="fig">5</xref> shows the relation between the number of torsion angles and CPU usage. A linear relation was observed between the number of torsion angles and CPU usage. Both figures clearly show a direct relationship where the increase in the number of torsion angles leads to an increase in both docking duration and CPU usage. These results were expected because AutoDock Vina generates conformations by rotating each rotatable bond by a certain interval. For example, if a ligand has one torsion angle and Vina samples conformations at 10Å interval, then the number of possible conformations is <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$360/10 = 36$$\end{document}</tex-math><mml:math id="M10"><mml:mrow><mml:mn>360</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>10</mml:mn><mml:mo>=</mml:mo><mml:mn>36</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq5.gif"/></alternatives></inline-formula>. In another example where the ligand has five torsion angles, the number of generated conformations would be <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$(360/10)^5= 60466176$$\end{document}</tex-math><mml:math id="M12"><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>360</mml:mn><mml:mo stretchy="false">/</mml:mo><mml:mn>10</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>5</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn>60466176</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq6.gif"/></alternatives></inline-formula> conformations. The number of computations is proportional to the number of torsional angles, which is reflected in a longer duration and higher CPU usage. AutoDock Vina allows no more than 32 torsion angles, where a larger number of torsion angles leads to impractical time-wise calculations.</p>
        <p id="Par66">The median duration of the total docking experiments is 57.54 seconds, with a 1st quartile duration of 32.74 seconds and a 3rd quartile duration of 97.19 seconds. The median CPU usage of the total docking experiments is 398% (<inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sim$$\end{document}</tex-math><mml:math id="M14"><mml:mo>∼</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq7.gif"/></alternatives></inline-formula>4 out of 12 cores) with a 1st quartile CPU usage of 213% (<inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sim$$\end{document}</tex-math><mml:math id="M16"><mml:mo>∼</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq8.gif"/></alternatives></inline-formula>2 out of 12 cores) and a 3rd quartile CPU usage of 699% (<inline-formula id="IEq9"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\sim$$\end{document}</tex-math><mml:math id="M18"><mml:mo>∼</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq9.gif"/></alternatives></inline-formula>7 out of 12 cores). The CPU usage results show that the docking performance could be optimized better by allocating a smaller number of cores per docking (7 cores, for example), which allows more dockings to be performed in parallel.<fig id="Fig4"><label>Fig. 4</label><caption><p>Docking performance—Duration versus number of torsion angles</p></caption><graphic xlink:href="13321_2021_573_Fig4_HTML" id="MO5"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Docking performance—CPU usage versus number of torsion angles</p></caption><graphic xlink:href="13321_2021_573_Fig5_HTML" id="MO6"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec14">
      <title>Dataset construction implementation</title>
      <p id="Par67">All tools and packages used and developed for this project were encapsulated in independent Docker containers. The Docker containers were deployed on a cluster infrastructure running OpenShift, a container-orchestration system based on Kubernetes [<xref ref-type="bibr" rid="CR63">63</xref>]. The code and the Docker images used in this project can be found in this GitHub repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/BiGCAT-UM/PSnpBind-Build">https://github.com/BiGCAT-UM/PSnpBind-Build</ext-link>. The GitHub repository describes the individual steps for building the PSnpBind database where each tool involved has its own repository. The GitHub repositories are linked to DockerHub, a cloud-based repository for automatic building, storing and distributing container images. DockerHub automatically rebuilds the Docker image after each commit to the corresponding GitHub repository. Hence, it saves time and effort. For deployment, the DSRI available at Maastricht University was used to deploy the dockerized tools used in this research. DSRI through OpenShift platform can deploy Docker images by grabbing them from DockerHub which also facilitates the integration between the source projects on GitHub and the production deployments. Ten nodes from DSRI were utilized to perform the calculations in the different steps of the methodology. Each node provides 128 cores to perform computations in parallel. That adds up to 1280 cores that were used to perform the most computationally-extensive steps: energy minimization and docking. Finally, all the repositories where preserved through Zenodo [<xref ref-type="bibr" rid="CR64">64</xref>] and a DOI was minted for each one of them.</p>
    </sec>
    <sec id="Sec15">
      <title>Web application implementation</title>
      <p id="Par68">The PSnpBind front-end (Fig. <xref rid="Fig6" ref-type="fig">6</xref>) is implemented using modern web standards and tools (HTML5 [<xref ref-type="bibr" rid="CR65">65</xref>], CSS3 [<xref ref-type="bibr" rid="CR66">66</xref>], JQuery<xref ref-type="fn" rid="Fn1">1</xref> and Bootstrap<xref ref-type="fn" rid="Fn2">2</xref>) and responsive web designs were adopted. Thus, the website can automatically adapt and resize the page layout depending on the screen sizes of a variety of devices. The back-end, allowing communication with the database and handling of the front-end requests was written in Java and used the Spring framework. For the database, MySQL community edition was used to store information about the proteins, mutations, ligands and dockings, and their corresponding folder names in the constructed dataset. The SQL database allows to explore the dataset metadata and links the docking conformers and protein structures files on the disk to the web interface in order to be visualized in the browser. The Jmol molecular visualization library [<xref ref-type="bibr" rid="CR67">67</xref>] was used to visualize protein-ligand complexes with highlighting the mutations and identifying the close contacts of the drug. The Chemistry Develpment Kit (CDK) [<xref ref-type="bibr" rid="CR68">68</xref>] library v2.3 is used to generate ligands descriptors. The PSnpBind web application is wrapped in a Docker image, allowing quick and easy deployment on local servers and the cloud. All the code, for both front-end and back-end, is available on GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/BiGCAT-UM/psnpbind-webapp">https://github.com/BiGCAT-UM/psnpbind-webapp</ext-link>).<fig id="Fig6"><label>Fig. 6</label><caption><p>PSnpBind web interface</p></caption><graphic xlink:href="13321_2021_573_Fig6_HTML" id="MO7"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec16">
    <title>Utility and discussion</title>
    <sec id="Sec17">
      <title>Simple search</title>
      <p id="Par69">The search function aims at enabling the user to find or filter the ligands bound to one of the PSnpBind database protein structures based on an input string. The users can search using criteria like CHEMBL ID (of the ligand). String search uses native MySQL regex matching functionality, allowing flexible search in all the columns corresponding to the search criteria. The input string is first wrapped in a regular expression, then the DB is queried against the appropriate fields, and the results, if exists, are sent back to the front-end.</p>
    </sec>
    <sec id="Sec18">
      <title>PSnpBind REST API</title>
      <p id="Par70">A RESTful API is also provided to the users of PSnpBind web application to obtain information about proteins, mutations, ligands and binding complexes (dockings) that are hosted in the database. The API returns JSON objects with a structure corresponding to the entity in question. The API follows the OpenAPI<xref ref-type="fn" rid="Fn3">3</xref> specification v3, a standardization for how REST APIs are described. A Swagger<xref ref-type="fn" rid="Fn4">4</xref> UI has been implemented to provide documentation, an interface for users, with little or no programming experience, to ‘talk’ to the services, to quickly and easily formulate queries with the services and obtain dynamically generated source code for popular programming languages, such as Java, Perl, Python and Ruby. The full documentation of the API can be found on (<ext-link ext-link-type="uri" xlink:href="https://psnpbind.org/swagger-ui.html">https://psnpbind.org/swagger-ui.html</ext-link>). The PSnpBind supports the following endpoints:</p>
      <p id="Par71">/api/v1/protein/list</p>
      <p id="Par72">/api/v1/protein/PDB_ID</p>
      <p id="Par73">/api/v1/protein/uuid/PROTEIN_UUID</p>
      <p id="Par74">/api/v1/protein/PDB_ID/variants</p>
      <p id="Par75">/api/v1/variant/VARIANT_ID</p>
      <p id="Par76">/api/v1/variant/uuid/VARIANT_UUID</p>
      <p id="Par77">/api/v1/ligand/CHEMBL_ID</p>
      <p id="Par78">/api/v1/ligand/uuid/CHEMBL_UUID</p>
      <p id="Par79">/api/v1/variant/VARIANT_ID/ligand/CHEMBL_ID</p>
      <p id="Par80">/api/v1/docking/VARIANT_LIGAND_UUID</p>
    </sec>
    <sec id="Sec19">
      <title>Molecular visualization</title>
      <p id="Par81">PSnpBind web interface gives users the ability to visualize every protein–ligand docking complex from the constructed dataset using Jmol [<xref ref-type="bibr" rid="CR67">67</xref>], an open-source Java viewer for chemical structures in 3D. In order to visualize the molecules in the browser, JSmol [<xref ref-type="bibr" rid="CR69">69</xref>], the HTML5 modality of Jmol, was used which is embeddable in the browser and has all the functionalities of Jmol (the standalone application). The JSmol panel in the web interface (Fig. <xref rid="Fig7" ref-type="fig">7</xref>) gives a full visualization experience to explore the protein-ligand complex including: mutation highlight, five different protein representation styles (stick, ball and stick, wireframe, space-filling and cartoon models), molecular surface display and ligand contacts highlights. The nearest contacts of the ligand are visualized using colored disks. The disks indicate where the van der Waals radii of atoms overlaps. The colors indicate how close the contact is: yellow <inline-formula id="IEq10"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$=$$\end{document}</tex-math><mml:math id="M20"><mml:mo>=</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq10.gif"/></alternatives></inline-formula> close, orange <inline-formula id="IEq11"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$=$$\end{document}</tex-math><mml:math id="M22"><mml:mo>=</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq11.gif"/></alternatives></inline-formula> touching, and red <inline-formula id="IEq12"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$=$$\end{document}</tex-math><mml:math id="M24"><mml:mo>=</mml:mo></mml:math><inline-graphic xlink:href="13321_2021_573_Article_IEq12.gif"/></alternatives></inline-formula> overlapping.<fig id="Fig7"><label>Fig. 7</label><caption><p>ligand contacts visualization using Jmol. The figure shows the nearest contacts of the ligand. The disks indicate where the van der Waals radii of atoms overlaps. The colors indicate how close the contact is: yellow = close, orange = touching, and red = overlapping</p></caption><graphic xlink:href="13321_2021_573_Fig7_HTML" id="MO8"/></fig></p>
    </sec>
    <sec id="Sec20">
      <title>Structured data (Bioschemas.org) and FAIR implementation</title>
      <p id="Par82">PSnpBind was built with FAIR principles in mind from the ground up. All the FAIR principles were addressed as far as possible. Also, structured markup using JSON-LD is provided for all the pages of proteins and ligands in the web interface. The Bioschemas.org vocabulary [<xref ref-type="bibr" rid="CR70">70</xref>] was used to annotate the protein information and provide links to PDB, NCBI Taxon and UniProt. Figure <xref rid="Fig8" ref-type="fig">8</xref> shows an example of the JSON-LD generated for one of the protein pages. Also, Table <xref rid="Tab4" ref-type="table">4</xref> shows a summary of the FAIR principles and their implementation status in PSnpBind.<fig id="Fig8"><label>Fig. 8</label><caption><p>JSON-LD markup example for a PSnpBind protein page, the shemas.org and bioschemas.org vocabularies are used to describe the protein, providing information about the structure, sequence, taxon and IDs</p></caption><graphic xlink:href="13321_2021_573_Fig8_HTML" id="MO9"/></fig><table-wrap id="Tab4"><label>Table 4</label><caption><p>Summary of the FAIR principle and their implementation status in PSnpBind</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><bold>FAIR principle</bold></th><th align="left"><bold>Implemented</bold></th><th align="left"><bold>Comment</bold></th></tr></thead><tbody><tr><td align="left">F1. (Meta)data are assigned a globally unique and persistent identifier</td><td align="left">Yes</td><td align="left">Internal UUID is generated for each instance of proteins, mutations, ligands and dockings. The database as a whole. the web application, and the libraries made for executing the steps of the workflow are all preserved through Zeonodo with a DOI assigned to each of them.</td></tr><tr><td align="left">F2. Data are described with rich metadata</td><td align="left">Yes</td><td align="left">All instances are annotated and well described from the relevant sources (PDB, UniProt, NCBI Taxon and ChEMBL)</td></tr><tr><td align="left">F3. Metadata clearly and explicitly include the identifier of the data they describe</td><td align="left">Yes</td><td align="left"/></tr><tr><td align="left">F4. (Meta)data are registered or indexed in a searchable resource</td><td align="left">Yes</td><td align="left">The dataset will be submitted to re3data.org and Google Dataset</td></tr><tr><td align="left">A1. (Meta)data are retrievable by their identifier using a standardised communications protocol</td><td align="left">Yes</td><td align="left">HTTP(S) protocol is used with a REST API for all communications with the server</td></tr><tr><td align="left">A2. Metadata are accessible, even when the data are no longer available</td><td align="left">Yes</td><td align="left">In progress</td></tr><tr><td align="left">I1. (Meta)data use a formal, accessible, shared, and broadly applicable language for knowledge representation.</td><td align="left">Yes</td><td align="left">JSON-LD is used to describe main protein entities. The REST API adopts the OpenAPI specification v3 and it is described using Swagger.</td></tr><tr><td align="left">I2. (Meta)data use vocabularies that follow FAIR principles</td><td align="left">Yes</td><td align="left">The structured markup (JSON-LD) uses the schema.org and bioschema.org vocabularies.</td></tr><tr><td align="left">R1. (Meta)data are richly described with a plurality of accurate and relevant attributes</td><td align="left">Yes</td><td align="left">License, usage and provenance info are all provided.</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec21">
    <title>Conclusion</title>
    <p id="Par83">PSnpBind is a large database of protein–ligand complexes covering a wide range of binding pocket mutations and a large small molecules’ landscape. This database can be used as a source of data for different types of studies, for example, developing machine learning algorithms to predict protein–ligand affinity or SNPs effect on it which requires an extensive amount of data with a wide coverage of mutation types and small molecules. Also, studies of protein-ligand interactions and conformer orientation changes across different mutated versions of a protein can be established using data from PSnpBind. Furthermore, it provides multiple ways of accessing the data through direct download, a web application and a REST API, all provided in compliance with the FAIR principles. PSnpBind is a valuable resource for new studies in related fields like drug discovery, pharmacogenomics, and structural bioinformatics.</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>SNP</term>
        <def>
          <p id="Par2">Single-nucleotide polymorphism</p>
        </def>
      </def-item>
      <def-item>
        <term>EM</term>
        <def>
          <p id="Par3">Energy minimzation</p>
        </def>
      </def-item>
      <def-item>
        <term>API</term>
        <def>
          <p id="Par4">Application programming interface</p>
        </def>
      </def-item>
      <def-item>
        <term>CASF</term>
        <def>
          <p id="Par5">Comparative assessment of scoring functions</p>
        </def>
      </def-item>
      <def-item>
        <term>SIFTS</term>
        <def>
          <p id="Par6">Structure integration with function, taxonomy, and sequence</p>
        </def>
      </def-item>
      <def-item>
        <term>MD</term>
        <def>
          <p id="Par7">Molecular dynamics</p>
        </def>
      </def-item>
      <def-item>
        <term>SBDD</term>
        <def>
          <p id="Par8">Structure-based drug design</p>
        </def>
      </def-item>
      <def-item>
        <term>SBVS</term>
        <def>
          <p id="Par9">Structure-based virtual screening</p>
        </def>
      </def-item>
      <def-item>
        <term>DSRI</term>
        <def>
          <p id="Par10">Data science research infrastructure</p>
        </def>
      </def-item>
      <def-item>
        <term>ADT</term>
        <def>
          <p id="Par11">AutoDock tools</p>
        </def>
      </def-item>
      <def-item>
        <term>CDK</term>
        <def>
          <p id="Par12">Chemistry Development Kit</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn id="Fn1">
      <label>1</label>
      <p id="Par85"><ext-link ext-link-type="uri" xlink:href="https://jquery.com/">https://jquery.com/</ext-link>.</p>
    </fn>
    <fn id="Fn2">
      <label>2</label>
      <p id="Par86"><ext-link ext-link-type="uri" xlink:href="https://getbootstrap.com/">https://getbootstrap.com/</ext-link>.</p>
    </fn>
    <fn id="Fn3">
      <label>3</label>
      <p id="Par87"><ext-link ext-link-type="uri" xlink:href="https://www.openapis.org">https://www.openapis.org</ext-link>.</p>
    </fn>
    <fn id="Fn4">
      <label>4</label>
      <p id="Par88"><ext-link ext-link-type="uri" xlink:href="https://swagger.io/">https://swagger.io/</ext-link>.</p>
    </fn>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <notes notes-type="author-contribution">
    <title>Authors' contributions</title>
    <p>AA designed and implemented the PSnpBind database construction workflow, developed the front-end and back-end of PSnpBind and wrote the manuscript. RC and EW supervised the project, reviewed the manuscript and gave feedback. CE reviewed the manuscript and gave feedback. All authors read and approved the final manuscript</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>All PSnpBind data, code to construct the database, and the code for the font- and the back-end of the PSnpBind online website are freely available without any restriction. The obtained dockings dataset can be downloaded from zenodo <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5281/zenodo.5112334">https://doi.org/10.5281/zenodo.5112334</ext-link>. Code of data processing and database construction workflow is available on GitHub <ext-link ext-link-type="uri" xlink:href="https://github.com/BiGCAT-UM/PSnpBind-Build">https://github.com/BiGCAT-UM/PSnpBind-Build</ext-link>. Code of the front-end and the back-end is also available on GitHub <ext-link ext-link-type="uri" xlink:href="https://github.com/BiGCAT-UM/psnpbind-webapp">https://github.com/BiGCAT-UM/psnpbind-webapp</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par84">The authors declare no conflict of interest.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Daly</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Pharmacogenetics and human genetic polymorphisms</article-title>
        <source>Biochem J</source>
        <year>2010</year>
        <volume>429</volume>
        <issue>3</issue>
        <fpage>435</fpage>
        <lpage>449</lpage>
        <pub-id pub-id-type="doi">10.1042/bj20100522</pub-id>
        <?supplied-pmid 20626352?>
        <pub-id pub-id-type="pmid">20626352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilke</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Dolan</surname>
            <given-names>ME</given-names>
          </name>
        </person-group>
        <article-title>Genetics and variable drug response</article-title>
        <source>JAMA.</source>
        <year>2011</year>
        <volume>306</volume>
        <fpage>3</fpage>
        <pub-id pub-id-type="doi">10.1001/jama.2011.998</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schärfe</surname>
            <given-names>CPI</given-names>
          </name>
          <name>
            <surname>Tremmel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schwab</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kohlbacher</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Marks</surname>
            <given-names>DS</given-names>
          </name>
        </person-group>
        <article-title>Genetic variation in human drug-related genes</article-title>
        <source>Genome Med</source>
        <year>2017</year>
        <pub-id pub-id-type="doi">10.1186/s13073-017-0502-5</pub-id>
        <?supplied-pmid 29273096?>
        <pub-id pub-id-type="pmid">29273096</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <mixed-citation publication-type="other">Rosello OP, Vlasova AV, Shichkova PA, Markov Y, Vlasov PK, Kondrashov FA (2017). Genomic analysis of human polymorphisms affecting drug-protein interactions. BoRxiv. 10.1101/119933</mixed-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yamada</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Nishi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nakata</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kinoshita</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Structural characterization of single nucleotide variants at ligand binding sites and enzyme active sites of human proteins</article-title>
        <source>Biophys Physicobiol</source>
        <year>2016</year>
        <volume>13</volume>
        <fpage>157</fpage>
        <lpage>163</lpage>
        <pub-id pub-id-type="doi">10.2142/biophysico.13.0_157</pub-id>
        <?supplied-pmid 27924270?>
        <pub-id pub-id-type="pmid">27924270</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bansal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Shukla</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ramteke</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>In silico screening of deleterious single nucleotide polymorphisms (SNPs) and molecular dynamics simulation of disease associated mutations in gene responsible for oculocutaneous albinism type 6 (OCA 6) disorder</article-title>
        <source>J Biomol Struct Dyn.</source>
        <year>2019</year>
        <volume>37</volume>
        <issue>13</issue>
        <fpage>3513</fpage>
        <lpage>3523</lpage>
        <pub-id pub-id-type="doi">10.1080/07391102.2018.1520649</pub-id>
        <?supplied-pmid 30204049?>
        <pub-id pub-id-type="pmid">30204049</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seifi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Walter</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms</article-title>
        <source>PLoS ONE.</source>
        <year>2018</year>
        <volume>13</volume>
        <issue>4</issue>
        <fpage>0195971</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0195971</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ansari</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Dass</surname>
            <given-names>JFP</given-names>
          </name>
          <name>
            <surname>Khan</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Identification and characterization of functional single nucleotide polymorphisms (SNPs) in Axin 1 gene: a molecular dynamics approach</article-title>
        <source>Cell Biochem Biophys</source>
        <year>2018</year>
        <volume>76</volume>
        <issue>1</issue>
        <fpage>173</fpage>
        <lpage>185</lpage>
        <pub-id pub-id-type="doi">10.1007/s12013-017-0818-1</pub-id>
        <?supplied-pmid 28770488?>
        <pub-id pub-id-type="pmid">28770488</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>George Priya Doss</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rajith</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chakraboty</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Balaji</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Magesh</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gowthami</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>In silico profiling and structural insights of missense mutations in RET protein kinase domain by molecular dynamics and docking approach</article-title>
        <source>Mol BioSyst.</source>
        <year>2014</year>
        <volume>10</volume>
        <issue>3</issue>
        <fpage>421</fpage>
        <lpage>436</lpage>
        <pub-id pub-id-type="doi">10.1039/C3MB70427K</pub-id>
        <?supplied-pmid 24336963?>
        <pub-id pub-id-type="pmid">24336963</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Priya Doss</surname>
            <given-names>CG</given-names>
          </name>
          <name>
            <surname>Chakraborty</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK Missense Mutations in structural perspective</article-title>
        <source>BioMed Res Int.</source>
        <year>2014</year>
        <volume>1</volume>
        <fpage>1</fpage>
        <lpage>14</lpage>
        <pub-id pub-id-type="doi">10.1155/2014/895831</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arshad</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bhatti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>John</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Identification and in silico analysis of functional SNPs of human TAGAP protein: a comprehensive study</article-title>
        <source>PLoS ONE.</source>
        <year>2018</year>
        <volume>13</volume>
        <fpage>1</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0188143</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>GRC</given-names>
          </name>
          <name>
            <surname>Da Silva</surname>
            <given-names>ANR</given-names>
          </name>
          <name>
            <surname>Do Nascimento</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>De Mesquita</surname>
            <given-names>JF</given-names>
          </name>
        </person-group>
        <article-title>In silico analysis and molecular dynamics simulation of human superoxide dismutase 3 (SOD3) genetic variants</article-title>
        <source>J Cell Biochem</source>
        <year>2019</year>
        <volume>120</volume>
        <issue>3</issue>
        <fpage>3583</fpage>
        <lpage>3598</lpage>
        <pub-id pub-id-type="doi">10.1002/jcb.27636</pub-id>
        <?supplied-pmid 30206983?>
        <pub-id pub-id-type="pmid">30206983</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <mixed-citation publication-type="other">Dakal TC, Kala D, Dhiman G, Yadav V, Krokhotin A, Dokholyan NV (2017). Predicting the functional consequences of non-synonymous single nucleotide polymorphisms in IL8 gene. Sci Rep. 7(1). <ext-link ext-link-type="uri" xlink:href="http://www.nature.com/articles/s41598-017-06575-4">http://www.nature.com/articles/s41598-017-06575-4</ext-link></mixed-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luu</surname>
            <given-names>TD</given-names>
          </name>
          <name>
            <surname>Rusu</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Walter</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ripp</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Moulinier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MSV3d: database of human MisSense variants mapped to 3D protein structure</article-title>
        <source>Database.</source>
        <year>2012</year>
        <volume>2012</volume>
        <issue>1</issue>
        <fpage>bas018</fpage>
        <pub-id pub-id-type="doi">10.1093/database/bas018</pub-id>
        <?supplied-pmid 22491796?>
        <pub-id pub-id-type="pmid">22491796</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Herrera Braga</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fraternali</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>PinSnps: structural and functional analysis of SNPs in the context of protein interaction networks</article-title>
        <source>Bioinformatics.</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>16</issue>
        <fpage>2534</fpage>
        <lpage>2536</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btw153</pub-id>
        <?supplied-pmid 27153707?>
        <pub-id pub-id-type="pmid">27153707</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ryan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Diekhans</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lien</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Karchin</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>LS-SNP/PDB: annotated non-synonymous SNPs mapped to Protein Data Bank structures</article-title>
        <source>Bioinformatics.</source>
        <year>2009</year>
        <volume>25</volume>
        <issue>11</issue>
        <fpage>1431</fpage>
        <lpage>1432</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btp242</pub-id>
        <?supplied-pmid 19369493?>
        <pub-id pub-id-type="pmid">19369493</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Solomon</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Kunik</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Simon</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kol</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Barel</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Lev</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>G23D: Online tool for mapping and visualization of genomic variants on 3D protein structures</article-title>
        <source>BMC Genomics.</source>
        <year>2016</year>
        <volume>17</volume>
        <fpage>1</fpage>
        <pub-id pub-id-type="doi">10.1186/s12864-016-3028-0</pub-id>
        <pub-id pub-id-type="pmid">26818753</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yue</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Melamud</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Moult</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>SNPs3D: candidate gene and SNP selection for association studies</article-title>
        <source>BMC Bioinform</source>
        <year>2006</year>
        <volume>7</volume>
        <fpage>166</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-7-166</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hurst</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>McMillan</surname>
            <given-names>LEM</given-names>
          </name>
          <name>
            <surname>Porter</surname>
            <given-names>CT</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fakorede</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>ACR</given-names>
          </name>
        </person-group>
        <article-title>The SAAPdb web resource: a large-scale structural analysis of mutant proteins</article-title>
        <source>Human Mutat</source>
        <year>2009</year>
        <volume>30</volume>
        <issue>4</issue>
        <fpage>616</fpage>
        <lpage>624</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.20898</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>An</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Madhavan</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>SNP2Structure: a Public and Versatile Resource for Mapping and Three-Dimensional Modeling of Missense SNPs on Human Protein Structures</article-title>
        <source>Comput Struct Biotechnol J.</source>
        <year>2015</year>
        <volume>13</volume>
        <fpage>514</fpage>
        <lpage>519</lpage>
        <pub-id pub-id-type="doi">10.1016/j.csbj.2015.09.002</pub-id>
        <?supplied-pmid 26949480?>
        <pub-id pub-id-type="pmid">26949480</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stitziel</surname>
            <given-names>NO</given-names>
          </name>
        </person-group>
        <article-title>topoSNP: a topographic database of non-synonymous single nucleotide polymorphisms with and without known disease association</article-title>
        <source>Nucleic Acids Res</source>
        <year>2004</year>
        <volume>32</volume>
        <issue>90001</issue>
        <fpage>520D</fpage>
        <lpage>522</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkh104</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kono</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yuasa</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nishiue</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yura</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>coliSNP database server mapping nsSNPs on protein structures</article-title>
        <source>Nucleic Acids Res</source>
        <year>2007</year>
        <volume>36</volume>
        <fpage>D409</fpage>
        <lpage>D413</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkm801</pub-id>
        <?supplied-pmid 17921498?>
        <pub-id pub-id-type="pmid">17921498</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gress</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ramensky</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Büch</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>StructMAn: annotation of single-nucleotide polymorphisms in the structural context</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <fpage>W463</fpage>
        <lpage>W468</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw364</pub-id>
        <?supplied-pmid 27150811?>
        <pub-id pub-id-type="pmid">27150811</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ofoegbu</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>David</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kelley</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Mezulis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Islam</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Mersmann</surname>
            <given-names>SF</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PhyreRisk: a dynamic web application to bridge genomics, proteomics and 3D structural data to guide interpretation of human genetic variants</article-title>
        <source>J Mol Biol</source>
        <year>2019</year>
        <volume>431</volume>
        <issue>13</issue>
        <fpage>2460</fpage>
        <lpage>2466</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jmb.2019.04.043</pub-id>
        <?supplied-pmid 31075275?>
        <pub-id pub-id-type="pmid">31075275</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The PDBbind aatabase: methodologies and updates</article-title>
        <source>J Med Chem</source>
        <year>2005</year>
        <volume>48</volume>
        <issue>12</issue>
        <fpage>4111</fpage>
        <lpage>4119</lpage>
        <pub-id pub-id-type="doi">10.1021/jm048957q</pub-id>
        <?supplied-pmid 15943484?>
        <pub-id pub-id-type="pmid">15943484</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
        </person-group>
        <article-title>The Protein Data Bank</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <?supplied-pmid 10592235?>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Apweiler</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>UniProt: the Universal Protein knowledgebase</article-title>
        <source>Nucleic Acids Res</source>
        <year>2004</year>
        <volume>32</volume>
        <issue>90001</issue>
        <fpage>115D</fpage>
        <lpage>119</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkh131</pub-id>
        <pub-id pub-id-type="pmid">14704348</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cunningham</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Rios</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>McLaren</surname>
            <given-names>WM</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pritchard</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ensembl variation resources</article-title>
        <source>BMC Genom</source>
        <year>2010</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>293</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-11-293</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Landrum</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Benson</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Chao</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chitipiralla</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>
        <source>Nucleic Acids Res</source>
        <year>2018</year>
        <volume>46</volume>
        <fpage>D1062</fpage>
        <lpage>D1067</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1153</pub-id>
        <?supplied-pmid 29165669?>
        <pub-id pub-id-type="pmid">29165669</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Velankar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dana</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van Ginkel</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gane</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SIFTS: Structure Integration with Function, Taxonomy and Sequences resource</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>41</volume>
        <fpage>D483</fpage>
        <lpage>D489</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1258</pub-id>
        <?supplied-pmid 23203869?>
        <pub-id pub-id-type="pmid">23203869</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gaulton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bellis</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Bento</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Chambers</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Davies</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hersey</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ChEMBL: a large-scale bioactivity database for drug discovery</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>D1100</fpage>
        <lpage>D1107</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkr777</pub-id>
        <?supplied-pmid 21948594?>
        <pub-id pub-id-type="pmid">21948594</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garbuzynskiy</surname>
            <given-names>SO</given-names>
          </name>
          <name>
            <surname>Melnik</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Lobanov</surname>
            <given-names>MY</given-names>
          </name>
          <name>
            <surname>Finkelstein</surname>
            <given-names>AV</given-names>
          </name>
          <name>
            <surname>Galzitskaya</surname>
            <given-names>OV</given-names>
          </name>
        </person-group>
        <article-title>Comparison of X-ray and NMR structures: is there a systematic difference in residue contacts between X-ray- and NMR-resolved protein structures?</article-title>
        <source>Proteins</source>
        <year>2005</year>
        <volume>60</volume>
        <issue>1</issue>
        <fpage>139</fpage>
        <lpage>147</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.20491</pub-id>
        <?supplied-pmid 15856480?>
        <pub-id pub-id-type="pmid">15856480</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comparative assessment of scoring functions: the CASF-2016 update</article-title>
        <source>J Chem Inform Model</source>
        <year>2019</year>
        <volume>59</volume>
        <issue>2</issue>
        <fpage>895</fpage>
        <lpage>913</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.jcim.8b00545</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of the performance of four molecular docking programs on a diverse set of protein-ligand complexes</article-title>
        <source>J Comput Chem</source>
        <year>2010</year>
        <volume>31</volume>
        <issue>11</issue>
        <fpage>2109</fpage>
        <lpage>2125</lpage>
        <pub-id pub-id-type="doi">10.1002/jcc.21498</pub-id>
        <?supplied-pmid 20127741?>
        <pub-id pub-id-type="pmid">20127741</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prlic</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yates</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bliven</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Rose</surname>
            <given-names>PW</given-names>
          </name>
          <name>
            <surname>Jacobsen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Troshin</surname>
            <given-names>PV</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>BioJava: an open-source framework for bioinformatics in 2012</article-title>
        <source>Bioinformatics.</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>20</issue>
        <fpage>2693</fpage>
        <lpage>2695</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts494</pub-id>
        <?supplied-pmid 22877863?>
        <pub-id pub-id-type="pmid">22877863</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Eils</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Schlesner</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Complex heatmaps reveal patterns and correlations in multidimensional genomic data</article-title>
        <source>Bioinformatics.</source>
        <year>2016</year>
        <volume>32</volume>
        <issue>18</issue>
        <fpage>2847</fpage>
        <lpage>2849</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btw313</pub-id>
        <?supplied-pmid 27207943?>
        <pub-id pub-id-type="pmid">27207943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schymkowitz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Borg</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stricher</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nys</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rousseau</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>The FoldX web server: an online force field</article-title>
        <source>Nucleic Acids Res</source>
        <year>2005</year>
        <volume>33</volume>
        <fpage>W382</fpage>
        <lpage>W388</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gki387</pub-id>
        <?supplied-pmid 15980494?>
        <pub-id pub-id-type="pmid">15980494</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Khan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vihinen</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Performance of protein stability predictors</article-title>
        <source>Human Mutat</source>
        <year>2010</year>
        <volume>31</volume>
        <issue>6</issue>
        <fpage>675</fpage>
        <lpage>684</lpage>
        <pub-id pub-id-type="doi">10.1002/humu.21242</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Potapov</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Cohen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schreiber</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Assessing computational methods for predicting protein stability upon mutation: good on average but not in the details</article-title>
        <source>Protein Eng Des Select</source>
        <year>2009</year>
        <volume>22</volume>
        <issue>9</issue>
        <fpage>553</fpage>
        <lpage>560</lpage>
        <pub-id pub-id-type="doi">10.1093/protein/gzp030</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Abraham</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Murtola</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schulz</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Páll</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Hess</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title>
        <source>SoftwareX.</source>
        <year>2015</year>
        <volume>1–2</volume>
        <fpage>19</fpage>
        <lpage>25</lpage>
        <pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>MacKerell</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Bashford</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bellott</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dunbrack</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Evanseck</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Field</surname>
            <given-names>MJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>All-atom empirical potential for molecular modeling and dynamics studies of proteins</article-title>
        <source>J Phys Chem B.</source>
        <year>1998</year>
        <volume>102</volume>
        <issue>18</issue>
        <fpage>3586</fpage>
        <lpage>3616</lpage>
        <pub-id pub-id-type="doi">10.1021/jp973084f</pub-id>
        <?supplied-pmid 24889800?>
        <pub-id pub-id-type="pmid">24889800</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jorgensen</surname>
            <given-names>WL</given-names>
          </name>
          <name>
            <surname>Chandrasekhar</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Madura</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Impey</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Klein</surname>
            <given-names>ML</given-names>
          </name>
        </person-group>
        <article-title>Comparison of simple potential functions for simulating liquid water</article-title>
        <source>J Chem Phys.</source>
        <year>1983</year>
        <volume>79</volume>
        <issue>2</issue>
        <fpage>926</fpage>
        <lpage>935</lpage>
        <pub-id pub-id-type="doi">10.1063/1.445869</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dudev</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Principles governing Mg, Ca, Zn binding and selectivity in proteins</article-title>
        <source>Chem Rev</source>
        <year>2003</year>
        <volume>103</volume>
        <issue>3</issue>
        <fpage>773</fpage>
        <lpage>788</lpage>
        <pub-id pub-id-type="doi">10.1021/cr020467n</pub-id>
        <?supplied-pmid 12630852?>
        <pub-id pub-id-type="pmid">12630852</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <mixed-citation publication-type="other">Astuti AD, Mutiara AB (2009). Performance analysis on molecular dynamics simulation of protein using GROMACS. arXivorg. 2009; <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/0912.0893v1">arXiv: 0912.0893v1</ext-link></mixed-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <mixed-citation publication-type="other">Gajula M, Kumar A, Ijaq J (2016). Protocol for Molecular Dynamics Simulations of Proteins. BIO-PROTOCOL. 6(23). <ext-link ext-link-type="uri" xlink:href="https://bio-protocol.org/e2051">https://bio-protocol.org/e2051</ext-link></mixed-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moreira</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Noutahi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lamoureux</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Burger</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Three-dimensional structure model and predicted ATP interaction rewiring of a deviant RNA ligase 2</article-title>
        <source>BMC Struct Biol</source>
        <year>2015</year>
        <pub-id pub-id-type="doi">10.1186/s12900-015-0046-0</pub-id>
        <?supplied-pmid 26449279?>
        <pub-id pub-id-type="pmid">26449279</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pereira</surname>
            <given-names>GRC</given-names>
          </name>
          <name>
            <surname>Tellini</surname>
            <given-names>GHAS</given-names>
          </name>
          <name>
            <surname>De Mesquita</surname>
            <given-names>JF</given-names>
          </name>
        </person-group>
        <article-title>In silico analysis of PFN1 related to amyotrophic lateral sclerosis</article-title>
        <source>PLoS ONE.</source>
        <year>2019</year>
        <volume>14</volume>
        <issue>6</issue>
        <fpage>e0215723</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0215723</pub-id>
        <?supplied-pmid 31216283?>
        <pub-id pub-id-type="pmid">31216283</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nguyen</surname>
            <given-names>TT</given-names>
          </name>
          <name>
            <surname>Viet</surname>
            <given-names>MH</given-names>
          </name>
        </person-group>
        <article-title>Effects of water models on binding affinity: evidence from all-atom simulation of binding of Tamiflu to A/H5N1 neuraminidase</article-title>
        <source>Sci World J.</source>
        <year>2014</year>
        <volume>1</volume>
        <fpage>1</fpage>
        <lpage>14</lpage>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>O’Boyle</surname>
            <given-names>NM</given-names>
          </name>
          <name>
            <surname>Banck</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Morley</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vandermeersch</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hutchison</surname>
            <given-names>GR</given-names>
          </name>
        </person-group>
        <article-title>Open Babel: an open chemical toolbox</article-title>
        <source>J Cheminform.</source>
        <year>2011</year>
        <volume>3</volume>
        <fpage>1</fpage>
        <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>
        <pub-id pub-id-type="pmid">21214931</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bajusz</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Rácz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Héberger</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?</article-title>
        <source>J Cheminform</source>
        <year>2015</year>
        <volume>7</volume>
        <fpage>1</fpage>
        <pub-id pub-id-type="doi">10.1186/s13321-015-0069-3</pub-id>
        <pub-id pub-id-type="pmid">25705261</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Halgren</surname>
            <given-names>TA</given-names>
          </name>
        </person-group>
        <article-title>Merck molecular force field. I, Basis, form, scope, parameterization, and performance of MMFF94</article-title>
        <source>J Comput Chem.</source>
        <year>1996</year>
        <volume>17</volume>
        <issue>5</issue>
        <fpage>490</fpage>
        <lpage>519</lpage>
        <pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199604)17:5/6&lt;490::AID-JCC1&gt;3.0.CO;2-P</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seidel</surname>
            <given-names>SAI</given-names>
          </name>
          <name>
            <surname>Wienken</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Geissler</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jerabek-Willemsen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Duhr</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Reiter</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Label-free microscale thermophoresis discriminates sites and affinity of protein-ligand binding</article-title>
        <source>Wiley.</source>
        <year>2012</year>
        <volume>51</volume>
        <issue>42</issue>
        <fpage>10656</fpage>
        <lpage>10659</lpage>
        <pub-id pub-id-type="doi">10.1002/anie.201204268</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jerabek-Willemsen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>André</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wanner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Duhr</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Baaske</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MicroScale thermophoresis: interaction analysis and beyond</article-title>
        <source>Elsevier BV.</source>
        <year>2014</year>
        <volume>1077</volume>
        <fpage>101</fpage>
        <lpage>113</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molstruc.2014.03.009</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <mixed-citation publication-type="other">Huang R, Bonnichon A, Claridge TDW, Leung IKH (2017). Protein-ligand binding affinity determination by the waterLOGSY method: An optimised approach considering ligand rebinding. Springer Science and Business Media LLC. 2017;7(1). 10.1038/srep43727</mixed-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Solution NMR spectroscopy in target-based drug discovery</article-title>
        <source>MDPI AG.</source>
        <year>2017</year>
        <volume>22</volume>
        <issue>9</issue>
        <fpage>1399</fpage>
        <pub-id pub-id-type="doi">10.3390/molecules22091399</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shuker</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Hajduk</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Meadows</surname>
            <given-names>RP</given-names>
          </name>
          <name>
            <surname>Fesik</surname>
            <given-names>SW</given-names>
          </name>
        </person-group>
        <article-title>Discovering high-affinity ligands for proteins: SAR by NMR</article-title>
        <source>Am Assoc Adv Sci.</source>
        <year>1996</year>
        <volume>274</volume>
        <issue>5292</issue>
        <fpage>1531</fpage>
        <lpage>1534</lpage>
        <pub-id pub-id-type="doi">10.1126/science.274.5292.1531</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <mixed-citation publication-type="other">Rezaei M, Li Y, Li X, Li C (2019). Improving the Accuracy of Protein-Ligand Binding Affinity Prediction by Deep Learning Models: Benchmark and Model. figshare. 2019;Available from: <ext-link ext-link-type="uri" xlink:href="https://chemrxiv.org/articles/Improving_the_Accuracy_of_Protein-Ligand_Binding_Affinity_Prediction_by_Deep_Learning_Models_Benchmark_and_Model/9866912">https://chemrxiv.org/articles/Improving_the_Accuracy_of_Protein-Ligand_Binding_Affinity_Prediction_by_Deep_Learning_Models_Benchmark_and_Model/9866912</ext-link></mixed-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kundu</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Paul</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Banerjee</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>A machine learning approach towards the prediction of protein-ligand binding affinity based on fundamental molecular properties</article-title>
        <source>RSC Adv</source>
        <year>2018</year>
        <volume>8</volume>
        <issue>22</issue>
        <fpage>12127</fpage>
        <lpage>12137</lpage>
        <pub-id pub-id-type="doi">10.1039/C8RA00003D</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Trott</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Olson</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title>
        <source>J Comput Chem.</source>
        <year>2009</year>
        <pub-id pub-id-type="doi">10.1002/jcc.21334</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weininger</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>a chemical language and information System. 1. Introduction to methodology and encoding rules</article-title>
        <source>J Chem Inf Comput Sci.</source>
        <year>1988</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>31</fpage>
        <lpage>36</lpage>
        <pub-id pub-id-type="doi">10.1021/ci00057a005</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Forli</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Huey</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pique</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Sanner</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Goodsell</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Olson</surname>
            <given-names>AJ</given-names>
          </name>
        </person-group>
        <article-title>Computational protein-ligand docking and virtual drug screening with the AutoDock suite</article-title>
        <source>Nature Protocols.</source>
        <year>2016</year>
        <volume>11</volume>
        <issue>5</issue>
        <fpage>905</fpage>
        <lpage>919</lpage>
        <pub-id pub-id-type="doi">10.1038/nprot.2016.051</pub-id>
        <?supplied-pmid 27077332?>
        <pub-id pub-id-type="pmid">27077332</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jaghoori</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Bleijlevens</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Olabarriaga</surname>
            <given-names>SD</given-names>
          </name>
        </person-group>
        <article-title>1001 Ways to run AutoDock Vina for virtual screening</article-title>
        <source>J Comput Aided Mol Des</source>
        <year>2016</year>
        <volume>30</volume>
        <issue>3</issue>
        <fpage>237</fpage>
        <lpage>249</lpage>
        <pub-id pub-id-type="doi">10.1007/s10822-016-9900-9</pub-id>
        <?supplied-pmid 26897747?>
        <pub-id pub-id-type="pmid">26897747</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <mixed-citation publication-type="other">Abdollahi Vayghan L, Saied MA, Toeroe M, Khendek F (2018). Deploying Microservice Based Applications with Kubernetes: Experiments and Lessons Learned. In: IEEE 11th International Conference on Cloud Computing (CLOUD). IEEE; . p. 970–973. <ext-link ext-link-type="uri" xlink:href="https://ieeexplore.ieee.org/document/8457916/">https://ieeexplore.ieee.org/document/8457916/</ext-link></mixed-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <mixed-citation publication-type="other">European Organization For Nuclear Research, OpenAIRE (2013). European Organization For Nuclear Research, OpenAIRE, editors. Zenodo. CERN; . <ext-link ext-link-type="uri" xlink:href="https://www.zenodo.org/">https://www.zenodo.org/</ext-link></mixed-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <mixed-citation publication-type="other">W3. W3, editor. HTML5, A vocabulary and associated APIs for HTML and XHTML. W3; 2011. <ext-link ext-link-type="uri" xlink:href="https://dev.w3.org/html5/spec-LC/">https://dev.w3.org/html5/spec-LC/</ext-link></mixed-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <mixed-citation publication-type="other">W3. W3, editor. Introduction to CSS3. W3; 2001. <ext-link ext-link-type="uri" xlink:href="https://www.w3.org/TR/2001/WD-css3-roadmap-20010523">https://www.w3.org/TR/2001/WD-css3-roadmap-20010523</ext-link></mixed-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herráez</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Biomolecules in the computer: Jmol to the rescue</article-title>
        <source>Biochem Mol Biol Educ</source>
        <year>2006</year>
        <volume>34</volume>
        <issue>4</issue>
        <fpage>255</fpage>
        <lpage>261</lpage>
        <pub-id pub-id-type="doi">10.1002/bmb.2006.494034042644</pub-id>
        <?supplied-pmid 21638687?>
        <pub-id pub-id-type="pmid">21638687</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Steinbeck</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kuhn</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Horlacher</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Luttmann</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Willighagen</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>The Chemistry Development Kit (CDK): an open-source java Library for Chemo- and Bioinformatics</article-title>
        <source>J Chem Inform Comput Sci</source>
        <year>2003</year>
        <volume>43</volume>
        <issue>2</issue>
        <fpage>493</fpage>
        <lpage>500</lpage>
        <pub-id pub-id-type="doi">10.1021/ci025584y</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanson</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Prilusky</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Renjian</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Nakane</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sussman</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>JSmol and the Next-Generation Web-Based representation of 3D molecular structure as applied toproteopedia</article-title>
        <source>Israel J Chem</source>
        <year>2013</year>
        <volume>53</volume>
        <issue>3</issue>
        <fpage>207</fpage>
        <lpage>216</lpage>
        <pub-id pub-id-type="doi">10.1002/ijch.201300024</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <mixed-citation publication-type="other">Gray CA A J G Goble, R J. Bioschemas (2017): From Potato Salad to Protein Annotation. In: In International Semantic Web Conference (Posters, Demos &amp; Industry Tracks). In International Semantic Web Conference (Posters, Demos &amp; Industry Tracks). p. 1–10. <ext-link ext-link-type="uri" xlink:href="https://bioschemas.org">https://bioschemas.org</ext-link></mixed-citation>
    </ref>
  </ref-list>
</back>
